Vita Capital VI Limited

The secondary market price for the Vita Capital VI Limited (Series 2021-1) mortality catastrophe bond transaction that was sponsored by global reinsurance firm Swiss Re has dropped, with the market seemingly anticipating an increasing chance of losses being paid under the terms of the notes.

According to our sources, the Vita Capital VI Limited (Series 2021-1) mortality catastrophe bond transaction that was sponsored by global reinsurance firm Swiss Re, is viewed as at-risk of attaching after preliminary data showed an increase in weighted mortality rates in 2022 for the US and the UK.

Swiss Re has successfully upsized its new Vita Capital VI Limited (Series 2021-1) mortality catastrophe bond transaction to $120 million, just below its revised upper-end target for the deal.

Global reinsurance giant Swiss Re is aiming to upsize its new Vita Capital VI Limited (Series 2021-1) mortality catastrophe bond transaction, with the targeted issuance now lifted to between $100 million and $125 million of extreme mortality protection, we’re told.

Global reinsurance company Swiss Re is back in the capital markets in search of protection for its life reinsurance business, with a new Vita Capital VI Limited (Series 2021-1) mortality catastrophe bond deal that aims to secure $75 million or more of extreme mortality protection.

The first catastrophe bond rating action caused by the Covid-19 coronavirus pandemic has now been resolved and reverted, as S&P Global Ratings affirmed Swiss Re’s late 2015 Vita Capital VI Limited (Series 2015-1) transaction and removed it from a negative watch.

The first catastrophe bond rating action due to the Covid-19 coronavirus pandemic is unsurprisingly related to one of the few mortality cat bonds left in the market, Swiss Re’s late 2015 Vita Capital VI Limited (Series 2015-1) transaction, which has been put on a negative watch by S&P Global Ratings.

Global reinsurance firm Swiss Re’s latest catastrophe bond, the Vita Capital VI Limited (Series 2015-1) extreme mortality transaction, has remained at $100 million in size and the coupon pricing has been fixed at just below the middle of initial guidance.

One of the world’s largest reinsurance companies Swiss Re is returning to the capital markets with its first excess mortality catastrophe bond transaction since 2012, seeking at least $100 million of retrocession through a Vita Capital VI Limited (Series 2015-1) issuance.